62
Participants
Start Date
January 22, 2018
Primary Completion Date
October 26, 2021
Study Completion Date
October 26, 2021
XmAb18087
monoclonal bispecific antibody
Memorial Sloan Kettering Cancer Center, New York
University of Pennsylvania, Abramson Cancer Center, Philadelphia
University of Virginia, Charlottesville
Emory University, Atlanta
Mayo Clinic, Jacksonville
H. Lee Moffitt Cancer Center & Research Institute, Tampa
James Cancer Center, Columbus
Mayo Clinic, Rochester
Northwestern Medicine, Chicago
MD Anderson Cancer Center, Houston
University of Colorado, Anschutz Medical Campus, Aurora
Mayo Clinic, Phoenix
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles
City of Hope Medical Center, Duarte
Stanford Cancer Center, Palo Alto
Dana-Farber Cancer Institute, Boston
Collaborators (1)
ICON plc
INDUSTRY
Xencor, Inc.
INDUSTRY